Nano Pharmaceuticals
Market Cap
₹31 ₹31.00 Cr.
P/E
14.71
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.13
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
40.59 %
Institutions
Institutions
-
Market cap
Market cap
31.00 Cr
No. of Shareholders
No. of Shareholders
13,755
OPM (%)
OPM (%)
7.18 %
PE
PE
14.71
Prom Holding
Prom Holding
40.03 %
ROCE (%)
ROCE (%)
28.41
ROE (%)
ROE (%)
22.63
Sales
Sales
45.62 Cr
  • Gujarat Terce Labs.
  • JFL Life Sciences
  • Medistep Healthcare
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      29
      52W Range
      High
      60
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      10 Yes

      Positive for this company

      1 Neutral

      Neutral for this company

      5 No

      Negative for this company

      1 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Peer Comparison

      FAQs on Gujarat Terce Laboratories Ltd. Business

      Gujarat Terce Laboratories Limited, founded in 1985 in India, is a pharmaceutical company based in Gandhinagar, Gujarat.

      Gujarat Terce Labs. major competitors are JFL Life Sciences, Lasa Supergenerics, Deccan Health Care, Medistep Healthcare, Cian Healthcare, Welcure Drugs&Pharma, Chandra Bhagat Pharm.
      Market Cap of Gujarat Terce Labs. is ₹32 Crs.
      While the median market cap of its peers are ₹33 Crs.

      Gujarat Terce Labs. seems to be financially stable compared to its competitors.
      The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

      Company Filing

      2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
      Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
      Earnings Release
      Investor Presentation Feb Jun Feb May Aug Nov Feb May Aug Oct May Jan May Aug Nov Jan
      Conference Call
      Conference Call SummaryCon Call Summary

      Discussions & Analysis

      Gujarat Terce Laboratories Ltd.
      Ideas Dashboard
      Results
      Timeline
      Watchlist
      Portfolio
      Alerts
      Stock Screener
      Market
      Raw Material